Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-021633

Options or other derivatives

  • Director acquired 69,353 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DOUGLAS RICHARD Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +53,812 53,812 D
DOUGLAS RICHARD Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +13,917 13,917 D
DOUGLAS RICHARD Director 2022-06-07 Grant or award · Stock Option (Right to Buy) +1,624 1,624 D
Loading xslF345X03/doc4.xml…